Heterozygosity for Hypoxia Inducible Factor 1α Decreases the Incidence of Thymic Lymphomas in a p53 Mutant Mouse Model

被引:31
作者
Bertout, Jessica A. [2 ]
Patel, Shetal A.
Fryer, Benjamin H.
Durham, Amy C. [2 ]
Covello, Kelly L.
Olive, Kenneth P.
Goldschmidt, Michael H. [2 ]
Simon, M. Celeste [1 ]
机构
[1] Univ Penn, Sch Med, Howard Hughes Med Inst, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA
关键词
RENAL-CELL CARCINOMA; TUMOR-SUPPRESSOR; HIF-2-ALPHA PROMOTES; C-MYC; CANCER; MICE; LEUKEMIA; NOTCH1; HIF-1-ALPHA; EXPRESSION;
D O I
10.1158/0008-5472.CAN-08-4223
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia inducible factors (HIF) are critical mediators of the cellular response to decreased oxygen tension and arc over-expressed in a number of tumors. Although HIF1 alpha and HIF2 alpha share a high degree of sequence homology, recent work has shown that the two alpha subunits can have contrasting and tissue-specific effects on tumor growth. To directly compare the role of each HIF alpha subunit in spontaneous tumorigenesis, we bred a mouse model of expanded HIF2 alpha expression and Hif1 alpha(+/-) mice to homozygotes for the R270H mutation in p53. Here, we report that p53(R270H/R270H) mice, which have not been previously described, develop a unique tumor spectrum relative to p53(p270H/-) mice, including a high incidence of thymic lymphomas. Heterozygosity for Hif1 alpha significantly reduced the incidence of thymic lymphomas observed in this model. Moreover, reduced Hif1 alpha levels correlated with decreased stabilization of activated Notch1 and expression of the Notch target genes, Dtx1 and Nrarp. These observations uncover a novel role for HIF1 alpha in Notch pathway activation during T-cell lymphomagenesis. [Cancer Res 2009;69(7):3213-20]
引用
收藏
页码:3213 / 3220
页数:8
相关论文
共 40 条
[11]   Hypoxia-inducible factors: central regulators of the tumor phenotype [J].
Gordan, John D. ;
Simon, M. Celeste .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2007, 17 (01) :71-77
[12]   HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity [J].
Gordan, John D. ;
Bertout, Jessica A. ;
Hu, Cheng-Jun ;
Diehl, J. Alan ;
Simon, M. Celeste .
CANCER CELL, 2007, 11 (04) :335-347
[13]   Acute postnatal ablation of Hif-2α results in anemia [J].
Gruber, Michaela ;
Hu, Cheng-Jun ;
Johnson, Randall S. ;
Brown, Eric J. ;
Keith, Brian ;
Simon, M. Celeste .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (07) :2301-2306
[14]   Hypoxia requires Notch signaling to maintain the undifferentiated cell state [J].
Gustafsson, MV ;
Zheng, XW ;
Pereira, T ;
Gradin, K ;
Jin, SB ;
Lundkvist, J ;
Ruas, JL ;
Poellinger, L ;
Lendahl, U ;
Bondesson, M .
DEVELOPMENTAL CELL, 2005, 9 (05) :617-628
[15]   Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype [J].
Holmquist-Mengelbier, Linda ;
Fredlund, Erik ;
Lofstedt, Tobias ;
Noguera, Rosa ;
Navarro, Samuel ;
Nilsson, Helen ;
Pietras, Alexander ;
Vallon-Christersson, Johan ;
Borg, Ake ;
Gradin, Katarina ;
Poellinger, Lorenz ;
Pahlman, Sven .
CANCER CELL, 2006, 10 (05) :413-423
[16]   Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation [J].
Hu, CJ ;
Wang, LY ;
Chodosh, LA ;
Keith, B ;
Simon, MC .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (24) :9361-9374
[17]   The differential effects of mutant p53 alleles on advanced murine lung cancer [J].
Jackson, EL ;
Olive, KP ;
Tuveson, DA ;
Bronson, R ;
Crowley, D ;
Brown, M ;
Jacks, T .
CANCER RESEARCH, 2005, 65 (22) :10280-10288
[18]   Expression of ARNT, ARNT2, HIF1α, HIF2α and Ah receptor mRNAs in the developing mouse [J].
Jain, S ;
Maltepe, E ;
Lu, MM ;
Simon, C ;
Bradfield, CA .
MECHANISMS OF DEVELOPMENT, 1998, 73 (01) :117-123
[19]   Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth [J].
Kondo, K ;
Kim, WY ;
Lechpammer, M ;
Kaelin, WG .
PLOS BIOLOGY, 2003, 1 (03) :439-444
[20]   Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein [J].
Kondo, K ;
Klco, J ;
Nakamura, E ;
Lechpammer, M ;
Kaelin, WG .
CANCER CELL, 2002, 1 (03) :237-246